Now is the time for senior living leaders to act and re-imagine what resident-centered, modern care can look like, today and in the future. The post AI Is No Longer Optional in Senior Living – Here’s Why appeared first on MedCity News.
The Healthcare Revolution at Your Home In today’s fast-paced world, finding time to visit a doctor can feel like a major challenge. Long work hours, family duties, traffic jams, and packed clinics make getting medical care stressful and inconvenient. For many people, especially seniors or those with mobility issues, even a short trip to the…
Success with agentic AI won’t come from racing to adopt the flashiest tools. It will come from strategic alignment, understanding where AI can create real value, mitigating risk through thoughtful implementation, and ensuring transparency and oversight at every step. The post From Hype to Impact: How Pharma Can Use Agentic AI to Drive Efficiency and…
[Sponsored] AI-powered threats are overwhelming outdated IT defenses. Discover why email remains healthcare’s biggest cybersecurity vulnerability and what can be done to address it. The post AI-Driven Email Attacks Are Exploding. Is Your Healthcare Organization at Risk? appeared first on MedCity News.
Four years before Kimberly Gallagher enrolled in Medicaid herself, the public health insurance program’s rules prompted her to make an excruciating choice — to give up guardianship of her son so she could work as his caregiver. Now, another proposed twist in the rules could mean that, even though Missouri pays her to do that…
The last time a Republican-controlled Congress and President Donald Trump moved to slash Medicaid spending, in 2017, a key political force stood in their way: GOP governors. Now, as Congress steamrolls toward passing historic Medicaid cuts of about $1 trillion over 10 years through Trump’s tax and spending legislation, red-state governors are saying little publicly…
Bispecific antibodies are already available for treating multiple myeloma. FDA approval of Regeneron Pharmaceuticals’ new drug, Lynozyfic, comes with dosing flexibility that sets it apart from others in its class. The post FDA Approves Regeneron Multiple Myeloma Drug With Dosing Edge Over J&J and Pfizer Meds appeared first on MedCity News.
Catastrophic healthcare expenditures (CHE) are highly problematic for families are are unequally distributed throughout society. However, how can we quantify the incidence, intensity and inequality of CHE in a society? A paper by Ogwang and Mwabu (2025) provide one methodology by using the Watts poverty measure and adapting it to measure CHE. We first describe…
Nordic Capital acquired a majority stake in health data platform Arcadia. Together, the two aim to accelerate the company’s mission of advancing value-based care through AI and data analytics. Arcadia CEO Michael Meucci views the deal as both a validation of the company’s strategy and part of a broader wave of healthcare investments focused on…
Organon said OG-6219 did not beat a placebo in a mid-stage clinical trial whose main goal was to measure the change in pelvic pain caused by endometriosis. The twice-daily pill came from Organon’s 2021 acquisition of Forendo Pharma. The post Organon Stops Work on Endometriosis Drug After Failure in Phase 2 Test appeared first on…